1746
Z. Dinev et al. / Carbohydrate Research 341 (2006) 1743–1747
NMR (400 MHz, CDCl3): d 2.02–2.10 (m, 12H, 4 · CH3),
combined fractions were pooled, concentrated in vacuo
and purified a second time by flash chromatography
(10–25% H2O in acetonitrile) to give uridine 50-diphos-
3.57–5.80 (m, 7H, H-1,2,3,4,5,6a,6b).
1.2.3. Diphenyl 2,3,4,6-tetra-O-acetyl-a-D-(13C6)gluco-
pyranosyl phosphate (3). DMAP (2.20 g, 18.0 mmol)
was added to a solution of 2,3,4,6-tetra-O-acetyl-D-
(13C6)glucopyranose (2) (2.66 g, 7.51 mmol) in CH2Cl2
(53 mL) and stirred at rt for 15 min. The reaction mix-
ture was cooled to ꢀ10 ꢁC, then diphenyl chlorophos-
phate (3.75 mL, 18.1 mmol) was added dropwise. After
stirring for 1 h, the reaction mixture was diluted with
CH2Cl2 (50 mL) and washed successively with ice cold
water (2 · 100 mL), ice cold 0.5 M HCl (2 · 100 mL),
and satd aq NaHCO3 (2 · 100 mL). The organic frac-
tion was dried (MgSO4), concentrated in vacuo, and
purified by flash chromatography (40–50% EtOAc in
petroleum spirits) to give diphenyl 2,3,4,6-tetra-O-acet-
yl-a-D-(13C6)glucopyranosyl phosphate (3) as a pale
pho-2,3,4,6-tetra-O-acetyl-a-D-(13C6)glucopyranose
(5)
(2.14 g, 84%) as a white solid. 1H NMR (400 MHz,
D2O): d 1.88 (s, 3H, CH3), 1.91 (s, 3H, CH3), 1.94 (s,
3H, CH3), 1.97 (s, 3H, CH3), 3.75–5.53 (m, 7H, H-
1,2,3,4,5,6a,6b), 3.99–4.19 (m, 4H, H-20,30,40,50), 5.80
(d, J1 ;2 ¼ 4:0 Hz, 1H, H-10), 5.83 (d, J5 ;6 ¼ 8:0 Hz,
0
0
00 00
1H, H-500), 7.84 (d, J5 ;6 ¼ 8:0 Hz, 1H, H-600); 13C
00 00
NMR (100.5 MHz, D2O): d 20.24, 20.29, 20.30, 20.40
(4C, CH3), 61.51–62.01 (m, 1C, C-6), 65.13 (d,
JC5 ;P ¼ 5:3 Hz, C-50), 67.55–68.95 (m, 2C, H-4,5),
0
69.50–71.80 (m, 3C, C-2,3,30), 74.18 (C-20), 83.10 (d,
JC4 ;P ¼ 9:1 Hz, C-40), 88.82 (C-10), 92.20–92.69 (m, 1C,
0
C-1), 102.84 (C-500), 141.97 (C-600), 151.88 (C-200),
166.31 (C-400), 172.97 (·2), 173.25, 173.83 (4C, C@O);
31P NMR (161.8 MHz, D2O): d ꢀ11.74, ꢀ9.47 (2 · br
s, P-1,2); ESIMS m/z calcd for 13C6C17H32N2O21P2
[MꢀH]ꢀ: 739.1099. Found 739.1114. [M+Naꢀ2H]ꢀ:
761.0929. Found 761.0926.
1
yellow oil (2.70 g, 83%). H NMR (400 MHz, CDCl3):
d 1.81 (s, 3H, CH3), 1.99 (s, 3H, CH3), 2.00 (s, 6H,
CH3 · 2), 3.84 (dd, JC,H = 150 Hz, J6a,6b = 12.8 Hz,
1H, H-6b), 4.03 (dm, JC,H = 148 Hz, 1H, H-5), 4.15
(ddd, JC,H = 147 Hz, J6a,6b = 12.8 Hz, J5,6a = 3.6 Hz,
1H, H-6a), 5.00 (dm, JC,H = 146 Hz, 1H, H-2), 4.88–
5.72 (m, 2H, H-3,4), 6.04 (dm, JC,H = 180 Hz, 1H, H-
1); 13C NMR (100.5 MHz, CDCl3): d 20.21, 20.51,
20.58 (·2) (4C, CH3), 60.93 (d, JC,C = 44.2 Hz, 1C, C-
1.4. Bis(ammonium) uridine 50-diphospho-a-D-(13C6)-
glucose (6)
Uridine 50-diphospho-2,3,4,6-tetra-O-acetyl-a-D-(13C6)-
glucopyranose (5) (1.65 g, 2.23 mmol) was suspended
in a mixture of 0.1 M TEAB (60 mL) and CH3OH
(45 mL) and chilled to ꢀ40 ꢁC. Et3N (750 lL,
10.2 mmol) was then added and the reaction mixture
was stored at ꢀ20 ꢁC for 4 days with occasional mixing.
A mixture of 0.1 M TEAB (30 mL) and CH3OH
(22.5 mL) then Et3N (375 lL, 5.1 mmol) were added
and the reaction mixture was stored at ꢀ20 ꢁC for a fur-
ther 4 days. The reaction mixture was then concentrated
in vacuo, keeping the temperature below 30 ꢁC. The
resulting material was passed through size exclusion
resin (Bio-Gel P-2, 3.5 cm · 45 cm) eluted with 250 mM
NH4HCO3. The fractions containing the product were
pooled and lyophilized. The product was passed
through cation exchange resin (Dowex 50W X8-400,
ammonium form, 2 · 5 cm). Fractions containing the
product were pooled and lyophilized to give bis(ammo-
nium) uridine 50-diphospho-a-D-(13C6)glucose (6) as a
6), 68.87–70.09 (m, 4C, C-2,3,4,5), 94.95 (d, JC,C
=
44.2 Hz, 1C, C-1), 120.00–150.24 (4C, Ph), 169.32,
169.76, 169.95, 170.52 (4C, C@O); 31P NMR
(161.8 MHz, CDCl3): d ꢀ14.38 to ꢀ14.22 (m, 1P, P-1);
ESIMS m/z calcd for 13C6C20H29O13P [M+Na]+:
609.1445. Found 609.1445.
1.3. Uridine 50-diphospho-2,3,4,6-tetra-O-acetyl-a-D-
(13C6)glucopyranose (5)
A solution of diphenyl 2,3,4,6-tetra-O-acetyl-a-D-(13C6)-
glucopyranosyl phosphate (3) (2.01 g, 3.42 mmol) in
EtOAc/EtOH (1:1, 60 mL) containing PtO2 (486 mg)
was shaken under H2 in a Parr apparatus at 380 kPa
for 18 h. The reaction mixture was filtered through Cel-
ite, and the filtrate treated with Et3N (0.95 mL,
6.84 mmol), and then concentrated in vacuo to yield
crude bis(triethylammonium) 2,3,4,6-tetra-O-acetyl-a-
D-glucopyranosyl phosphate (4). Without purification,
this crude material was co-evaporated with dry pyridine
(3 · 20 mL). UMP-morpholidate (3.38 g, 4.91 mmol)
was co-evaporated with pyridine (3 · 20 mL), then trans-
ferred via a cannula into the reaction flask. The com-
bined reagents were co-evaporated with pyridine
(2 · 20 mL) then 1H-tetrazole (772 mg, 11.0 mmol) was
added and the reaction mixture stirred at rt for 24 h.
The reaction mixture was concentrated in vacuo and
the resulting material was purified by flash chromato-
graphy (7:2:1 then 5:2:1, EtOAc/CH3OH/H2O). The
1
white solid (1.28 g, 94%). H NMR (400 MHz, D2O):
d 3.05–4.15 (m, 9H, H-2,3,30,4,40,5,50,6a,6b), 4.19 (d,
J1 ;2 ¼ 3:6 Hz, 1H, H-20), 5.43 (dm, JC,H = 173 Hz,
0
0
1H, H-1), 5.74–5.80 (m, 2H, H-10,500), 7.77 (d, J5 ;6
¼
00 00
8:4 Hz, 1H, H-600); 13C NMR (100.5 MHz, D2O): d
0
60.99 (d, JC,C = 42.7 Hz, 1C, C-6), 65.63 (d, JC5 ;P
¼
5:3 Hz, 1C, C-50), 70.02 (ddd, JC3,C4 = 37.4 Hz,
JC4,C5 = 37.4 Hz, JC2,C4 = 3.0 Hz, 1C, C-4), 70.34 (s,
1C, C-30), 71.79–72.74 (m, 1C, C-2), 74.97 (m, 3C, C-
20,3,5), 83.93 (d, JC4 ;P ¼ 9:1 Hz, 1C, C-40), 89.08 (1C,
0
C-10), 96.29 (dm, JC1,C2 = 44.2 Hz, 1C, C-1), 103.37
(C-500), 142.33 (C-600), 152.56 (C-200), 166.98 (C-400); 31P